662 related articles for article (PubMed ID: 14571788)
21. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
[TBL] [Abstract][Full Text] [Related]
22. [Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy].
Zhang HJ; Yang JJ; Wang WX; Jiang X; Mao YJ; Yang CA; Guo JX
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):907-10. PubMed ID: 18782532
[TBL] [Abstract][Full Text] [Related]
23. Th1 polarization and low-T3 syndrome are correlated with hyperleptinemia in hemodialysis patients.
Liu ML; Huang ZY; Zhong XC; Liu SH; Xu G; Jiang TY; Xi WW; Yan WQ
J Nephrol; 2009; 22(4):515-22. PubMed ID: 19662608
[TBL] [Abstract][Full Text] [Related]
24. [Levels of anti-inflammatory cytokines interleukin-2, interleukin-8, and soluble interleukin-2 receptor in blood of patients with various forms of ischemic heart disease].
Mazurov VI; Stvolov SV; Linetskaia NE; Baldueva IA
Ter Arkh; 2001; 73(12):14-7. PubMed ID: 11858100
[TBL] [Abstract][Full Text] [Related]
25. Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C.
Tachibana Y; Nakamoto Y; Mukaida N; Kaneko S
Cancer Lett; 2007 Jun; 251(1):36-42. PubMed ID: 17240051
[TBL] [Abstract][Full Text] [Related]
26. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
[TBL] [Abstract][Full Text] [Related]
27. The role of a protease inhibitor against hepatectomy.
Gotohda N; Iwagaki H; Ozaki M; Konishi M; Nakagohri T; Takahashi S; Yagi T; Kinoshita T; Tanaka N
Hepatogastroenterology; 2006; 53(67):115-9. PubMed ID: 16506388
[TBL] [Abstract][Full Text] [Related]
28. [The significance of sIL-2R detection in various hepatic diseases].
Xuan SY; Jiang LM; Lu WH
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Apr; 18(2):92-4. PubMed ID: 9812507
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection.
Migita K; Abiru S; Maeda Y; Daikoku M; Ohata K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Hum Immunol; 2006; 67(1-2):27-32. PubMed ID: 16698422
[TBL] [Abstract][Full Text] [Related]
30. [Serum levels of soluble interleukin-2 receptor in alcoholic patients].
Sopeña B; Fernández-Rodríguez CM; Martínez Vázquez C; Méndez MX; de la Fuente J; Freire M; Arnillas E; Outon A
An Med Interna; 1998 Apr; 15(4):189-93. PubMed ID: 9608061
[TBL] [Abstract][Full Text] [Related]
31. The serum levels of soluble interleukin-2 receptor levels in patients with obstructive jaundice.
Yüceyar H; Kokuludag A; Coker A; Ersöz G; Keskinoglu A; Güler A; Cavusoglu H
Hepatogastroenterology; 1996; 43(10):949-53. PubMed ID: 8884319
[TBL] [Abstract][Full Text] [Related]
32. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
[TBL] [Abstract][Full Text] [Related]
33. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
[TBL] [Abstract][Full Text] [Related]
34. Serum cytokine profiles in patients with adult onset Still's disease.
Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
[TBL] [Abstract][Full Text] [Related]
36. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
[TBL] [Abstract][Full Text] [Related]
37. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
38. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of proinflammatory cytokines serum levels during viral hepatitis type A.
Fota-Markowska H; Modrzewska R; Rolla-Szczepańska R; Bielec D; Krzowska-Firych J
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):209-13. PubMed ID: 16145982
[TBL] [Abstract][Full Text] [Related]
40. The analysis of the usefulness of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in patients with poor hepatic reserve by serial measurements of IL-6, cytokine antagonists, and C-reactive protein.
Sadamori H; Yagi T; Kanaoka Y; Morimoto Y; Inagaki M; Ishikawa T; Matsukawa H; Matsuda H; Iwagaki H; Tanaka N
Surg Endosc; 2003 Mar; 17(3):510-4. PubMed ID: 12399851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
